Raymond James Financial Inc Amphastar Pharmaceuticals, Inc. Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 29,672 shares of AMPH stock, worth $771,768. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,672
Previous 92,904
68.06%
Holding current value
$771,768
Previous $3.45 Million
75.07%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AMPH
# of Institutions
257Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$155 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$63 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$57.5 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$41.7 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$35.3 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.27B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...